A live Webinar session highlights management of Type 2 Diabetes


Incretin Impressions

A live Webinar session highlights
management of Type 2 Diabetes

Impression series is aimed at enhancing
outlook to widen perspectives

Over the past many years Pakistan has faced a significant rise in the number of patients being diagnosed with Type 2 Diabetes. The WHO Global status report on non-communicable diseases shows that NCDs (including diabetes) are a major cause of morbidity and mortality. Therefore, this rising incidence of Diabetes Mellitus needs to be addressed keeping in view the latest treatment modalities available.
MSD’s Incretin Impressions – Novel Outlook to Diabetes Management, a live webinar session in collaboration with OBS Pakistan (strategic partners of MSD), was held in Karachi, Islamabad and Lahore simultaneously on February 16, 2013. The program was attended by prominent medical professionals from all over the country, and reflected as an effort for bringing a paradigm shift in Type 2 Diabetes Management. The sessions started early in the morning where two foreign speakers were engaged to deliver lectures on Incretin Based Therapies.
Prof. Timothy Davis, from University of Western Australia, presented on DPP-IV Inhibition and its role in Type 2 Diabetes Management. Prof. Davis spoke about treatment targets, their determinants, Gliptins, their place in the treatment algorithm, and shed light on their pros and cons, and efficacy studies. He also covered recent studies of intensive treatment and results of glycaemic intervention. Treatment goals and comparison between intensive and conventional therapies were also thoroughly discussed.
The second speaker was Dr. Sanjay Kalra, a consultant Endocrinologist at Bharti Hospital, Karnal, India. Dr. Karla serves as Executive Editor of Indian Journal of Endocrinology and Metabolism, and is Vice President of South Asian Federation of Endocrine Societies. Dr. Karla presented on Positioning Incretin Based Therapies: A Case Study Based Approach, and discussed HbA1c lowering, hypoglycemia, cardiac and hepatic safety associated with DPP-IV inhibitors. Dr. Karla put forward cases where DPP-IV Inhibitor options should be considered, and discussed various safety analysis studies.
The sessions were highly interactive between the speaker and audience through an online Q&A hub, which was a chat module specially designed to entertain queries from the audience. Dr. Karla answered questions raised by all three stations, and discussed global practices as per the patient demographics.
The lectures were also reviewed by each station’s panel of experts, which constituted experienced opinion leaders from all regions who chaired the respective sessions. The expert panelists included Prof. Ataullah Khan, Prof. Javed Akhtar, Prof. Zaman Shaikh, Prof. Najmul Islam, Prof. Saeed Mahar, Dr. Yusuf Kamal, Dr. Fatima Jawad, Dr. Khurram Shahid, Dr. Qamar Masood from Karachi, Dr. Abbas Raza from Lahore, and Prof. A. H. Aamir, Prof. Jamal Zafar, and Dr. Saleem Qureshi from Islamabad.
The panelists also entertained further queries and presented their views on the discussion that took place. The panelists were then presented mementoes while participants were presented certificates. This was first of the many academic development sessions planned by OBS and MSD, and will continue to cascade knowledge from an international platform, to enhance the experience sharing process of medical practitioners in Pakistan.(PR)

© Professional Medical Publications. All rights reserved.